Cargando…
Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology.
It has been suggested that tamoxifen may improve the efficacy of medical castration with luteinising hormone-releasing hormone analogues, but very few data have so far been published concerning the clinical and endocrinological activity of this therapeutic modality. In this phase II multicentre tria...
Autores principales: | Buzzoni, R., Biganzoli, L., Bajetta, E., Celio, L., Fornasiero, A., Mariani, L., Zilembo, N., Di Bartolomeo, M., Di Leo, A., Arcangeli, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033795/ https://www.ncbi.nlm.nih.gov/pubmed/7734310 |
Ejemplares similares
-
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
por: Bajetta, E., et al.
Publicado: (1998) -
The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot study.
por: Di Leo, A., et al.
Publicado: (1994) -
Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.
por: Zilembo, N., et al.
Publicado: (1995) -
Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer.
por: Bajetta, E., et al.
Publicado: (1994) -
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
por: Dixon, A. R., et al.
Publicado: (1990)